Biohit Oyj

Board/Management Information • Feb 24, 2017

Biohit Oyj - Managers' Transactions

Biohit Oyj - Managers' Transactions

Biohit Oyj - Managers' Transactions, February 24, 2017 at 2:50 pm local time
(EET)

Person subject to the notification requirement
Name: Nordström, Niklas
Position: Chief Financial Officer

---

Initial Notification
Reference number: 74370089ATTSNBXJVT29_20170224110621_9

---

Issuer
Name: Biohit Oyj
LEI: 74370089ATTSNBXJVT29

---

Transaction details
Transaction date: 2017-02-23
Venue: NASDAQ HELSINKI LTD (XHEL)
Nature of the transaction: Subscription
Further details:
Linked to stock option programme

Instrument: Financial Instrument Linked to a Share or a Debt
Instrument
ISIN: FI4000219324

Volume: 2303
Unit price: 2,27660 Euro

Aggregated transactions
Volume: 2303
Volume weighted average price: 2.27660 Euro

Additional information:

CEO Semi Korpela, Biohit Oyj
tel. +358 9 773 861
investor.relations@biohit.fi
www.biohithealthcare.com

Biohit in brief

Biohit Oyj is a globally operating Finnish biotechnology company. Biohit’s
mission is “Innovating for Health” – we produce innovative products and
services to promote research and early diagnosis. Biohit is headquartered in
Helsinki, Finland, and has subsidiaries in Italy and the UK. Biohit's Series B
share (BIOBV) is quoted on Nasdaq Helsinki in the Small cap/Healthcare group.
www.biohithealthcare.com